@article{22508, keywords = {Adolescent, Adult, Analysis of Variance, Antibiotics, Antitubercular, DNA, Complementary, Drug Therapy, Combination, Female, Gene Expression, Glucocorticoids, Humans, Immunohistochemistry, leprosy, Male, Methylprednisolone, Middle Aged, Prednisolone, Toll-Like Receptor 2, Toll-Like Receptor 4, Young Adult}, author = {Walker S L and Roberts C H and Atkinson S E and Khadge S and Macdonald M and Neupane K D and Ranjit C and Sapkota B R and Dhakal S and Hawksworth R A and Mahat K and Ruchal S and Hamal S and Hagge D A and Lockwood DN}, title = {The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions.}, abstract = {
BACKGROUND: Leprosy is complicated by immunological reactions which can occur before, during and after successful completion of multidrug therapy. Genetic studies have suggested that polymorphisms in toll-like receptors (TLRs) may affect the susceptibility of an individual with leprosy to developing Type 1 reactions.
OBJECTIVES: To examine the gene and protein expression of TLRs in the cutaneous lesions of leprosy Type 1 reactions at the onset of reaction and during systemic corticosteroid therapy.
METHODS: Patients who were being treated for leprosy type 1 reactions with corticosteroids as part of a randomized controlled trial of corticosteroid treatment had skin biopsies performed before, during and at the end of treatment. The gene and protein expression of TLR2 and TLR4 were measured.
RESULTS: We have demonstrated that the gene hARP-P0 is a suitable control gene for TLR gene expression studies in this population. The gene and protein expression of TLR2 and TLR4 were both reduced significantly during corticosteroid treatment.
CONCLUSIONS: This is the first study to examine the expression of TLR2 and TLR4 in vivo in individuals experiencing leprosy Type 1 reactions. The data support the possibility of an important role for TLR2 and TLR4 in the pathogenesis of this important complication of leprosy.
}, year = {2012}, journal = {The British journal of dermatology}, volume = {167}, pages = {29-35}, month = {2012 Jul}, publisher = {Blackwell Scientific Publications}, address = {Oxford}, issn = {1365-2133}, doi = {10.1111/j.1365-2133.2012.10891.x}, language = {eng}, }